New Delhi, July 12, 2022 (GLOBE NEWSWIRE) — The global wearable injectors market is growing at a high CAGR because of the growing burden of chronic diseases, and high demand for advanced drug delivery. Moreover, emerging economies, such as China, Japan, India, etc., offer ample growth opportunities to the global wearable injectors market due to their high population and expanding investment towards healthcare infrastructure development….
A recent study, conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global wearable injectors market was worth USD 6.6 billion in the year 2020. According to the analysts, the market is estimated to grow at a CAGR of 9.8%, earning revenue of around USD 12.6 billion by the end of 2027. The growth of the global wearable injectors market is attributable to the increasing geriatric population and growing burden of chronic diseases, high demand for advanced drug delivery, and increasing compliance for controlled drug delivery. Moreover, emerging economies, such as China, Japan, India, etc., offer ample growth opportunities to the global wearable injectors market due to their high population and expanding investment towards healthcare infrastructure development. However, alternative drug delivery methods are hindering the growth of the global market.
Introduction of Smart Features Projected to Drive the Global Wearable Injectors Market
The prominently growing demand for wearable…
